DDX5 and breast cancer: These PAK5-mediated modifications consequently increase oncogenic miR-10b biogenesis by augmenting the interaction of DDX5 with the Drosha-DGCR8 complex, facilitating pri-miR-10b cleavage and maturation in breast cancer (Fig. 2).